z-logo
open-access-imgOpen Access
Abstract 1059: Targeting IDH1/2 mutant cancers with unique combinations of DNA repair inhibitors
Author(s) -
Amrita Sule,
Ranjini K. Sundaram,
Ranjit S. Bindra
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-1059
Subject(s) - olaparib , cancer research , isocitrate dehydrogenase , synthetic lethality , idh1 , biology , dna repair , poly adp ribose polymerase , carcinogenesis , mutant , parp inhibitor , dna damage , myeloid leukemia , mutation , homologous recombination , cancer , dna , polymerase , gene , genetics , enzyme , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here